CV Sciences, Inc. (OTCMKTS:CVSI) Sees Large Increase in Short Interest

CV Sciences, Inc. (OTCMKTS:CVSIGet Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 27,600 shares, a growth of 305.9% from the March 15th total of 6,800 shares. Based on an average trading volume of 818,700 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Stock Performance

Shares of CVSI remained flat at $0.04 during trading on Friday. 291,225 shares of the company’s stock were exchanged, compared to its average volume of 236,329. The business’s fifty day moving average is $0.04 and its 200-day moving average is $0.04. The firm has a market cap of $6.22 million, a PE ratio of 1.90 and a beta of 0.62. CV Sciences has a 1-year low of $0.03 and a 1-year high of $0.06.

CV Sciences (OTCMKTS:CVSIGet Free Report) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.01) EPS for the quarter. CV Sciences had a return on equity of 80.98% and a net margin of 19.38%. The firm had revenue of $3.80 million for the quarter.

About CV Sciences

(Get Free Report)

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.

See Also

Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with's FREE daily email newsletter.